KAZIA THERAPEUTICS-SPON ADR (KZIA)

US48669G1058 - ADR

0.56  +0.06 (+11.46%)

After market: 0.55 -0.01 (-1.79%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

KAZIA THERAPEUTICS-SPON ADR

NASDAQ:KZIA (10/21/2024, 5:57:54 PM)

After market: 0.55 -0.01 (-1.79%)

0.56

+0.06 (+11.46%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS SubIndustry
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Chartmill High Growth Momentum
EPS Q2Q%
Sales Q2Q%
CRS
6 Month51.78%
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap16.68M
Shares
PEN/A
Fwd PE74.38
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

KZIA Daily chart

Company Profile

Kazia Therapeutics Ltd is a AU-based company operating in Biotechnology industry. The company is headquartered in Sydney, New South Wales. Kazia Therapeutics Limited is an oncology focused drug development company. The firm is engaged in the pharmaceutical research and development. Its lead program includes Paxalisib and EVT801. Paxalisib is a small molecule inhibitor of the PI3K / Akt / mTOR pathway, a central regulator of growth and cell division that is dysregulated in many types of cancer. Paxalisib is being developed for several forms of brain cancer. EVT801 is a small molecule inhibitor of vascular endothelial growth factor receptor 3 (VEGFR3), which is critical to the development of new blood vessels and lymphatic vessels in a growing tumor, as well as to the metastasis of tumors to distant sites in the body. EVT801 is an inhibitor of VEGFR3, a cellular receptor for VEGF. The Company’s drug candidates are designed to treat disease, such as brain cancer, renal cancer, and liver cancer.

Company Info

KAZIA THERAPEUTICS-SPON ADR

Three International Towers Level 24,, 300 Barangaroo Avenue

Sydney NEW SOUTH WALES 2000

P: 1161298780088

CEO: James Garner

Employees: 13

Website: https://www.kaziatherapeutics.com/

KZIA News

ChartMill News Image3 days ago - ChartmillDiscover the top movers in Friday's after-hours session and stay informed about the post-market dynamics.

The US market regular session of Friday is over, let's have a look at the top gainers and losers in the after hours session today.

ChartMill News Image4 days ago - ChartmillWhich stocks are moving on Thursday?

Keep an eye on the top gainers and losers in Thursday's session, as they reflect the most notable price movements.

ChartMill News Image4 days ago - ChartmillWhich stocks are experiencing notable movement on Thursday?

These stocks are moving in today's session

ChartMill News Image4 days ago - ChartmillThere are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Thursday.

In today's session, there are notable price gaps in the US markets on Thursday. Take a closer look at the stocks that are gap up and gap down.

News Image6 days ago - USA News GroupBreast Cancer Awareness Month Sees Biotech Advancements and Worrying Trends for Young Women

/PRNewswire/ -- With every October, breast cancer awareness surges thanks to very effective campaigns and new developments in breast cancer treatment. However,...

News Image19 days ago - Kazia Therapeutics LimitedKazia Therapeutics Announces Presentation of Promising Phase I Data Evaluating Concurrent Paxalisib and Radiation Therapy in Patients with Solid Tumor Brain Metastases or Leptomeningeal Metastases Harboring PI3K Pathway Mutations at the American Society

/PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, announced the presentation of data from a Phase I...

KZIA Twits

Here you can normally see the latest stock twits on KZIA, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example